Riverbend Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Riverbend Wealth Management's LLY Position: Q3 2026 in Review
Riverbend Wealth Management increased its Eli Lilly (LLY) stake by 0.64% in Q3 2026, buying an estimated $15.3K and bringing the position to 2,043 shares worth $2.36M. The position accounts for 1.07% of the portfolio, ranked #25.
Riverbend Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.44M in Q2 2026. 2,227 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Riverbend Wealth Management held 2,043 shares of Eli Lilly worth $2.36M as of Q3 2026.
- Riverbend Wealth Management bought 13 Eli Lilly shares in Q3 2026, an estimated $15.3K.
- Eli Lilly made up 1.07% of Riverbend Wealth Management's portfolio in Q3 2026, its #25 holding.
- Riverbend Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- Riverbend Wealth Management's Eli Lilly position peaked at $2.44M in Q2 2026.
- 2,227 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Riverbend Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.